Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. USO
2. META
3. NVDA
4. SPY
5. ONON
6. DCOY
7. MSFT
8. AZO
9. RCL
10. VKTX

Go back to Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress
Compugen Ltd (NASDAQ: CGEN) Delayed: 2.49 --0 (-0%)
Previous Close $2.49    52 Week High $7.79 
Open $2.49    52 Week Low $4.32 
Day High $2.49    P/E N/A 
Day Low $2.49    EPS $-0.36 
Volume 259       

Compugen Ltd (NASDAQ: CGEN) Delayed: 2.49 --0 (-0%)
Previous Close $2.49    52 Week High $7.79 
Open $2.49    52 Week Low $4.32 
Day High $2.49    P/E N/A 
Day Low $2.49    EPS $-0.36 
Volume 259